Morphocell Technologies
PrivateLast Round
Series A
Dec 1, 2025
Total Funding Raised
$91.68M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Morphocell Technologies is a biotechnology company developing stem cell–derived tissue and organ replacement therapies with an initial focus on liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Morphocell Technologies Comparables
Compare Morphocell Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellite Bio | 88% | |
| LyGenesis | 88% | |
| HepaTx Corporation | 85% | |
Morphocell Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2025 | ||||
| Grant | Jun 19, 2025 | ||||
| Series A | Feb 1, 2024 | ||||
| Seed | Jul 7, 2021 | ||||
| Grant | Mar 2, 2020 |
Key People
Founding team and executive leadership
Morphocell Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gensen Capital | Series A |
| Stem Cell Network | Seed, Grant, Pre Seed |
| Investissement Québec | Series A |
| Investissement Québec | Series A |
| Consortium Québécois sur la découverte du médicament | Grant, Seed |
| CDP Venture Capital SGR | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
$10M round completed.
- Jul 7, 2021
$979K raised with Takeda and others participating.
Morphocell Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Morphocell Technologies's valuation, stock price, and market status.